Bivalent malaria vaccine(Novavax/CPL Biologicals/ICGEB)
N/A
Report date: 2024/09/04 13:56:19
Base Information
Drug NameBivalent malaria vaccine(Novavax/CPL Biologicals/ICGEB)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovavaxInternational Center for Genetic Engineering and BiotechnologyCpl Biologicals
China Registration ClassN/A
Develop Information
Active CompaniesCpl BiologicalsNovavaxInternational Center for Genetic Engineering and Biotechnology
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A